Taking the ABIM AHFTC Board or MOC Exam in November? Prepare with the HFSA AHFTC Board Certification Review!
2019 | HFSA

MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM

Practice News Industry

MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM

For more information, visit the MyoKardia website.